Metabolic Engineering of Escherichia coli for De Novo Production of 1,2-Butanediol
ACS Synthetic Biology · 2024
DOI: 10.1021/acssynbio.3c00606 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, 2024. Verfasst von Nan Qin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Industrial Biocatalysis (Ministry of Education), Department of Chemical Engineering, Tsinghua University, Beijing 100084, China. Hauptthemen laut MEDLINE: Escherichia coli, Metabolic Engineering. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Industrial Biocatalysis (Ministry of Education), Department of Chemical Engineering, Tsinghua University, Beijing 100084, China.
- School of Physiology, Pharmacology & Neuroscience, Faculty of Life Sciences, University of Bristol, Bristol BS8 1TD, United Kingdom.
- Center for Synthetic and Systems Biology, Tsinghua University, Beijing 100084, China.
ORCID-Profile: Zhen Chen
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Qin, N., Zhu, F., Liu, Y., Liu, D., & Chen, Z. (2024). Metabolic Engineering of Escherichia coli for De Novo Production of 1,2-Butanediol. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.3c00606
Vancouver
Qin N, Zhu F, Liu Y, Liu D, Chen Z. Metabolic Engineering of Escherichia coli for De Novo Production of 1,2-Butanediol. ACS Synthetic Biology. 2024. doi:10.1021/acssynbio.3c00606
BibTeX
@article{Qin2024,
author = {Qin, Nan and Zhu, Fanghuan and Liu, Yanyan and Liu, Dehua and Chen, Zhen},
title = {Metabolic Engineering of Escherichia coli for De Novo Production of 1,2-Butanediol},
journal = {ACS Synthetic Biology},
year = {2024},
doi = {10.1021/acssynbio.3c00606}
}
EUVIMED